No rhetoric. Four facts from this month.

One month. Four mechanisms affecting the same victim.

And industry is not alone. Farmers: the phasing-out of the CAP, fertiliser restrictions and restrictions on animal trade (such as the cultivated-meat ban of 11 June). Capital: Pillar Two top-up tax, wealth-accrual tax and DAC9 reporting. SMEs: CSRD, CSDDD, CBAM import reporting and EU AI Act compliance. Energy: ETS2 for buildings and transport from 2027, gas phase-out and biomass restrictions. Inventors: UPC costs, patent opposition proceedings and IP guidelines that hamper innovation instead of accelerating it.

One pipeline. Six sectors. One pattern.

Europe has six lifelines: industry, SMEs, farmers, energy, capital and inventors. This is where the money comes from for healthcare, education, defence and pensions. No production, no money, no society. Do the maths.

Those six lifelines are now being severed by the pipeline that depends on them.

And for what? For climate targets from 2015, in a world of 2026. Texas has no ETS. China has no CBAM. India has no Pillar Two. What Brussels is doing uniquely, it is doing against its own industry. Not out of malice. That is the pathology.

The living proof that it can be done differently: Carbon-Alert BiCRS / Ethanol

Before we draw the parallel with medicine, here is one concrete example. A working route that is now available. Not hypothetical. Not decades away. Implementable today.

Carbon-Alert Ltd has developed a two-track product that solves exactly the problem Brussels is trying to tackle with CBAM, the ETS and RED III — but without killing Europe’s own industry.

Track 1 · BiCRS through anoxic biomass injection

Equatorial belt, 10° north to 10° south. Per hectare per year:

• 400 tonnes of fresh biomass
• × 23.5% dry-matter fraction = 94 tonnes of dry matter
• × 47% carbon = 44 tonnes of C in the plant in total
• × 92.5% retention under anoxic conditions = 40.9 tonnes of C sequestered
• × 3.666 (CO₂/C) = 150 tonnes of CO₂ above ground
• + 50 tonnes of CO₂ in the root mass below ground
• = 200 tonnes of CO₂ permanently sequestered per hectare per year

Mobile cell-disruption and injection equipment comes to the plot. The biomass is liquefied on site and injected directly beneath its own roots. No transport. No plant. No logistics chain. The carbon remains permanently in the soil beneath the crop. An in-situ economy.

Track 2 · Bioethanol as a separate second route

Different hectares, different operations. Harvested biomass is transported to a local fermentation and distillation plant (50–100 km, as at a Brazilian sugar-cane plant). The bioethanol leaves the equatorial producing country by tanker for European ports. A full substitute for petrol and diesel. Climate-neutral through a closed carbon cycle.

The cost difference Brussels does not want to see

What one hectare yields — for Congo, for Europe

A Congolese farmer switches from cassava (€300 per hectare per year) to contract-based BiCRS biomass. 200 tonnes of CO₂ × €40 = €8,000 gross per hectare per year. After operator margins and operating costs, he retains €2,000–€3,000 net — seven to ten times his current income.

At national level: the Democratic Republic of the Congo, with 2.8 million hectares under BiCRS contracts, receives €22.4 billion per year gross — approximately 20% of current GDP. Indonesia with 2.1 Mha: €16.8 billion per year. Brazil for the Amazon fringe: €22.4 billion per year. Not as charity, but as a commercial relationship in which the partner country supplies what it has a comparative advantage in (climate, sunlight and water), while Europe pays for what it lacks comparatively (climate policy, industrial competitiveness and energy independence).

What this does for the six European lifelines

• Industry pays neither CBAM nor the ETS. Carbon-Alert provides climate compensation at €40/tonne instead of €78/tonne. The competitive disadvantage disappears.
• SMEs receive CSRD reporting backed by working figures: a European carbon-removal chain with traceable source tonnes.
• Farmers in Europe remain farmers, because existing agriculture does not have to compete with biomass allocation. Equatorial production is additional, not substitutive.
• Energy gains its own carbon cycle — bioethanol as a direct replacement for fossil fuel, produced in partner countries where solar radiation is unlimited.
• Capital gains an investment opportunity with measurable returns: €40/tonne in revenue, €12–€18/tonne in margin, scalable to 14 million hectares worldwide.
• Inventors gain recognition for what RED III currently excludes — the biomass route, in-situ injection and anoxic storage: three patentable innovations that Brussels is actively blocking.

One product. Two tracks. Six lifelines kept intact instead of severed.

What Brussels does with it

Nothing.

RED III phases out food-and-feed feedstocks. Bioethanol from sugar cane, maize and cassava is excluded from the RFNBO quotas. At the same time, hydrogen — infrastructure that does not yet exist in Europe — is given a guaranteed 10% transport market by 2040.

The Carbon-Alert BiCRS route does not fit the Brussels model because it was not devised by an EU Directorate-General. It comes from Malta, from an entrepreneur, from a patented innovation. That is a double threat to an autoimmune system: not only alternative policy, but also alternative authority.

And so it is ignored. Not refuted. Not assessed. Not tested. Ignored.

For the full calculation of what this could save and generate for Brussels — including the scenario analysis that Brussels itself would need to undertake — see The Brussels Impact Map — BiCRS version. Net effect: +23% to +106% per scenario by 2030, instead of the current net loss of 5–15%.

Carbon-Alert is therefore not “one of the alternatives”. It is the concrete proof that the diseased leadership is actively looking away from a route that works. Just as an autoimmune T-cell actively looks away from the diseased cell it should recognise as its own.

Why does nobody think?

How can this be? Educated commissioners. DGs with decades of experience. Entire directorates equipped with economic models. And yet this.

Genuine thinking requires three things.

Observing what is there. The diseased leadership sees only its own Green Deal models.

Questioning one’s own assumptions. Anyone within the Commission who asks aloud “is CBAM actually doing what we want?” loses their portfolio.

Taking responsibility. It came out of the impact assessment. It was set out in the Council Conclusions. It was fixed in the trilogue. Nobody decides personally — and so nobody truly decides to think.

Those who do not observe do not question. Those who do not question do not decide. Those who do not decide do not think.

That is why calls for “better coordination” or “more dialogue with industry” do not work. A system that does not think does not think better simply because you ask it to.

The disease has a name

In medicine, we know this. Autoimmune disease. The body attacks its own organs. The pancreas, joints, myelin, thyroid, intestines.

The attacking cells are not malicious. They are doing their job. The problem lies in recognition. The body’s own tissue is mistaken for an enemy.

The immune system cannot see its own mistake. Every attempt at correction is treated as a threat and neutralised.

Read this description again. Replace “body” with “Europe”. Replace “immune system” with “Brussels”. It fits word for word.

Why a new Commission will solve nothing

The cell line is diseased, not the individual cell.

A new Commissioner comes from the same university, the same permanent civil service, the same impact assessments, the same Council corridors. He can do nothing but take the same decisions. The DG produces them, not him.

Von der Leyen or her successor makes no difference. It is not the individuals who cause the autoimmune reaction — it is the structure that programmes those individuals to become autoantibodies.

Remove the cell line and form a new one.

The treatment

Five medical routes. Five political translations — now in Brussels form.

1 · Dampen the symptoms

Recovery & Resilience Facility, NextGenEU, "Just Transition Fund", subsidies for affected sectors via Temporary Decarbonisation Fund. Prolongs the illness. Makes the affected industry dependent on the attacking leadership. Do not do it.

2 · Remove specific institutions

Just as CAR-T kills the faulty B-cell line. Specifically, this month:

• CBAM: withdraw or fundamentally reform it — export rebate mandatory.
• ETS expansion (ETS2): freeze it — no levy on housing and transport as long as there is no European energy alternative.
• Pillar Two: suspend it for green and industrial investment incentives.
• RED III food-and-feed exclusion: reverse it — treat bioethanol as equivalent to hydrogen.
• CSDDD and CSRD: revise them — no reporting requirement without a demonstrated net benefit.

Five decisions. Before the end of 2026. Non-negotiable.

3 · Complete reset

Treaty revision, reorganisation of the Commission, revision of the ECB mandate, consideration of an exit for specific Member States. Works — or destroys. Only if routes 2 and 4 are refused. Held in reserve.

4 · New bodies alongside the old

Do not reform the Commission — establish a European Productivity Council alongside it, with direct representation from industry, SMEs, farmers and inventors. Do not try to persuade ECON — establish a European BiCRS Coalition of countries that want to retain production (Germany, France, the Netherlands, Italy, Poland, the Czech Republic). Do not hope that the EP will reform itself — establish a European Federal Council in which productive sectors have voting rights alongside the parties.

Construction alongside demolition. The old will become irrelevant by itself.

5 · The nutritional foundation

Europe's own energy via BiCRS / bioethanol. Our own food sovereignty. A productive euro that finances innovation. Wealth accumulation for SMEs and employees instead of financial conglomerates. Education for industrial reality instead of climate models. Without this, nothing will endure.

What happens if we do nothing

The course of the illness is documented. Other continents have already been through it.

Productive industry moves to Texas, Shanghai and Mumbai. SMEs shut down or are sold. Farmers sell to investment funds or leave. Energy becomes import-dependent — LNG from the US, hydrogen from Morocco, solar panels from China. Capital flees to 0% jurisdictions. Inventors patent in the US, not in Europe.

European citizens are left with higher prices, shrinking employment, import-dependent energy, thinner pensions and poorer healthcare.

Ten years. Then recovery is no longer possible.

Over to you

Brussels will not cure itself. An autoimmune system does not recognise its own error.

You do.

You are the German engineer whose factory is moving to Texas. The Italian family-business owner whose succession has become unaffordable. The Spanish farmer whose CAP subsidy is disappearing. The French inventor whose patent nobody will finance. The Dutch owner-director whose Box 3 is based on fiction. The Maltese craftsman whose energy bill is exploding.

You are also the healthy counterforce. The Treg cell that can sustain recovery. But only if you rouse yourself — across national borders, against the Brussels canon.

Recognise the illness. Name it. Demand the treatment. Do not wait for the patient.